There is one clinical trial.
The aim of this study is to evaluate the effectiveness of MLS laser therapy as a treatment for pulmonary complications due to COVID-19 infection.
Description: ICU on vent, ICU not requiring ventilation, Discharge to Rehab requiring assistance, Discharge to Home unable to perform ADL's, Discharge to Home able to perform ADL's
Measure: Patient Disposition Post treatment Time: 7 daysDescription: Patients oxygen requirements pulse oximetry will be evaluated for change from pre and post individual treatment as well as end of protocol
Measure: oxygenation Time: Daily for 4 daysDescription: The change in pre treatment levels and 24 hours post final treatment
Measure: IL-6 levels Time: First four days of trialDescription: Pre treatment CXR will be compared to post treatment CXR using the RALE CXR evaluation scale
Measure: Chest Xray radiographic results Time: 7 DaysDescription: The change in pretreatment and post treatment BCRSS will be evaluated
Measure: Brescia-COVID Respiratory Severity Scale Time: 7 daysDescription: The change in pretreatment and post treatment scores will be evaluated
Measure: SMART-COP Score Time: 7 daysDescription: The change in pretreatment and post treatment scores will be evaluated
Measure: PSI Score Time: 7 daysDescription: The change in pretreatment and post treatment levels will be evaluated The change in pretreatment and post treatment levels will be evalutated
Measure: CRP levels Time: 7 days